This $1,250,604 federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) aims to reduce the burden of physical inactivity in Mexico through an urban equity approach. The primary awardee, the University of Texas at Austin, will conduct a mixed-methods study across up to 10 major metropolitan areas in Mexico to test multisectoral engagement methods for advancing the active dissemination and...
This $709,563 federal Project Grant, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to leverage transcriptomics, metabolomics, and genome-wide association data to propel understanding of the underlying mechanisms of severe obesity in Hispanic/Latino populations. The project, titled "Leveraging Metabolic Pathways and Gene Expression Data to Propel...
This Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support program (CFDA 93.310), provides $765,750 to the University of Arizona to investigate the relationship between acculturative stress and non-alcoholic fatty liver disease (NAFLD) severity among a sample of 150 Mexican-origin adults in southern Arizona. The study aims to (1) examine the association between acculturative stress and NAFLD severity, (2) explore the link between acculturative...
This Project Grant award of $182,689 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA program 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund research on survivorship trajectories after liver transplantation. The grant aims to: 1) characterize distinct post-liver transplant survivorship phenotypes, 2) investigate the relationship between survivorship phenotypes and outcomes like medication adherence and quality of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the development, implementation, and evaluation of FUERTE, a multi-component strategy to engage Hispanic men at risk of diabetes through Federally Qualified Health Centers (FQHCs). The key products and services to be delivered include: 1) Qualitative interviews with 30 FQHC stakeholders to...
The National Alliance For Hispanic Health was awarded a $750,000 Project Grant from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 Investigations and Technical Assistance program. The grant, titled "LIVERWISE: HEALTHY LIVER, HEALTHY LIFE!", aims to improve liver health outcomes within the Hispanic community. The project spans from Sep 30, 2024 to Sep 29, 2027 and will support research, surveillance, epidemiological investigations, and targeted health...
This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH), under the Minority Health and Health Disparities Research (CFDA 93.307) program, will fund a $2,996,886 study to test the efficacy and sustainability of a 12-month family-centered behavioral intervention called "Athletes for Life" (AFL). The intervention will be delivered in community recreation centers in San Diego, California...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund a $159,339 research project to evaluate biologic and social determinants of health impacting diabetes prevention and health equity among Latino patients. The key objectives are to: 1) develop and validate Type 2 diabetes risk prediction models incorporating electronic health record data,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $754,400.00 to The University of Texas Southwestern Medical Center to conduct research aimed at identifying adaptive genetic pathways and mutant clones that could potentially protect against chronic liver disease progression. The key products and services to be delivered under this 5-year...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $6,635,136 to the University of Texas Health Science Center at Houston (UTHealth) to conduct a 2-phase study on community-level barriers and facilitators for active transportation and leisure physical activity in low-income, urban middle school communities with high proportions of minoritized residents. The study aims...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research program (CFDA 93.307), is intended to develop and pilot test a culturally appropriate, multi-level lifestyle intervention for Hispanic/Latino patients with metabolic-dysfunction associated steatotic liver disease (MASLD).
The $513,169 award to the University of Texas Health Science Center at Houston will fund the adaptation and piloting of a lifestyle intervention that addresses multiple levels of influence on health behaviors, including the role of family members, healthcare providers, and access to social services. The proposed research aims to achieve clinically significant changes in physical activity, diet, and weight loss, as well as improvements in liver-related outcomes for this high-risk patient population. The project will utilize an explanatory sequential mixed-methods design and explore patient, family, and provider experiences to refine the multi-level, multi-domain intervention. Completion of this research will position the Principal Investigator, Dr. Natalia Heredia, to pursue a full-scale evaluation of the intervention's implementation and effectiveness through a future R01 grant application.